- Home
- AUBN vs HRTX Comparison
AUBN vs HRTX Comparison
Compare AUBN & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUBN | HRTX |
|---|---|---|
| Founded | 1907 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.8M | 90.1M |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | AUBN | HRTX |
|---|---|---|
| Price | $26.18 | $0.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 781.0 | ★ 2.9M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ 13.66 | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | $619,000.00 | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | $20.26 | ★ N/A |
| Revenue Growth | 0.81 | ★ 7.36 |
| 52 Week Low | $21.60 | $0.30 |
| 52 Week High | $28.88 | $1.58 |
Technical Indicators
Market Signals| Indicator | AUBN | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 35.63 |
| Support Level | $25.09 | N/A |
| Resistance Level | $27.00 | $0.46 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 28.92 | 15.51 |
Price Performance
Historical ComparisonAbout AUBN Auburn National Bancorporation Inc.
Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.